• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Otolaryngol . The coronavirus disease 2019: the prevalence, prognosis, and recovery from olfactory dysfunction (OD)

tetano

Editor, Senior Moderator
Acta Otolaryngol


. 2020 Nov 11;1-10.
doi: 10.1080/00016489.2020.1836397. Online ahead of print.
The coronavirus disease 2019: the prevalence, prognosis, and recovery from olfactory dysfunction (OD)


Seyed Hadi Samimi Ardestani[SUP] 1 [/SUP], Mojtaba Mohammadi Ardehali[SUP] 1 [/SUP], Mahtab Rabbani Anari[SUP] 1 [/SUP], Benyamin Rahmaty[SUP] 1 [/SUP], Reza Erfanian[SUP] 1 [/SUP], Maryam Akbari[SUP] 2 [/SUP], Zohre Motedayen[SUP] 3 [/SUP], Fahimeh Samimi Niya[SUP] 4 [/SUP], Radmehr Aminloo[SUP] 5 [/SUP], Farbod Farahbakhsh[SUP] 1 [/SUP], Ali Hosseininasab[SUP] 6 [/SUP], Babak Hassanlouei[SUP] 7 [/SUP], Naime Rezaian[SUP] 3 [/SUP], Zahra Mokhtari[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Many patients with coronavirus disease 2019 (COVID-19) complain from olfactory dysfunction (OD). Aims/objectives: To evaluate the prevalence, prognosis, and recovery from OD in COVID-19 patients.
Material and methods: In this study, patients with COVID-19 symptoms who were referred to six different tertiary referral centres were recruited after positive results for COVID-19. All patients were assessed for a one-month follow-up after the initial diagnosis of COVID-19.
Results: Three hundred and eleven patients with COVID-19 were recruited in the present study. Two hundred and seven patients (66.6%) had a recent history of OD. One hundred and seventy-eight patients had experienced OD as a primary symptom intercurrent to other COVID-19 symptoms or solely. Sixty-nine patients had OD at the time of presentation to referral centres. Headache and nasal obstruction had significant relationships with recovery from OD in this subgroup, and the platelet count was the most important predictor for the recovery from OD. One hundred seventy-nine (86.4%) patients were nearly or fully recovered from OD approximately a month after the onset of OD.
Conclusion: Headache, nasal obstruction, and platelet count may have specific roles as prognostic factors in the recovery from OD.

Keywords: Anosmia coronavirus disease 2019 (COVID-19); hyposmia olfactory dysfunction (OD).
 
Back
Top Bottom